Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Estriol
Drug ID BADD_D00829
Description A hydroxylated metabolite of estradiol or estrone that has a hydroxyl group at C3-beta, 16-alpha, and 17-beta position. Estriol is a major urinary estrogen. During pregnancy, large amount of estriol is produced by the placenta. Isomers with inversion of the hydroxyl group or groups are called epiestriol. Though estriol is used as part of the primarily North American phenomenon of bioidentical hormone replacement therapy, it is not approved for use by the FDA or Health Canada. It is however available in the United States by prescription filled only by compounding pharmacies. It has also been approved and marketed throughout Europe and Asia for approximately 40 years for the treatment of post-menopausal hot flashes.
Indications and Usage Used as a test to determine the general health of an unborn fetus.
Marketing Status approved; investigational; vet_approved
ATC Code G03CA04; G03CC06
DrugBank ID DB04573
KEGG ID D00185; D01986
MeSH ID D004964
PubChem ID 5756
TTD Drug ID D0Z1FX
NDC Product Code 38779-0732; 51552-1392; 73309-072; 82653-001; 49452-2794; 73377-070; 43647-234; 60870-0259; 76420-049; 44132-007; 44132-014; 51927-0265; 60722-0003; 60722-3004; 71448-0001; 12860-0259; 82653-002
UNII FB33469R8E
Synonyms Estriol | 16alpha,17beta-Estriol | 16alpha,17beta Estriol | (16alpha,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol | 16-alpha-Hydroxy-Estradiol | 16 alpha Hydroxy Estradiol | Ovestin | Epiestriol | 16beta-Hydroxy-Estradiol | 16beta Hydroxy Estradiol | (16beta,17beta)-Estra-1,3,5(10)-Triene-3,16,17-Triol | Estra-1,3,5(10)-Triene-3,16beta,17beta-Triol
Chemical Information
Molecular Formula C18H24O3
CAS Registry Number 50-27-1
SMILES CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Application site irritation08.02.01.003; 12.07.01.003---
Breast cancer16.10.01.001; 21.05.01.003---
Cerebrovascular accident17.08.01.007; 24.03.05.001--
Cervical discharge21.06.01.001---
Chloasma18.08.02.002; 23.05.01.001---
Dementia17.03.01.001; 19.20.02.001---
Embolism venous24.01.01.003---
Endometrial cancer16.12.02.001; 21.07.02.002---
Erythema multiforme10.01.03.015; 23.03.01.003--
Erythema nodosum10.02.01.020; 23.07.02.001---
Fluid retention14.05.06.002; 20.01.02.003---
Gallbladder disorder09.03.02.001---
Gastrointestinal disorder07.11.01.001---
Myocardial infarction02.02.02.007; 24.04.04.009--
Nausea07.01.07.001--
Neoplasm16.16.02.001---
Pain08.01.08.004--
Pelvic venous thrombosis24.01.02.008---
Pruritus23.03.12.001--
Pulmonary embolism22.06.02.001; 24.01.06.001---
Vascular purpura01.01.04.007; 23.06.01.008; 24.07.06.011---
Breast discomfort21.05.05.007---
Acute coronary syndrome02.02.02.015; 24.04.04.011---
Postmenopausal haemorrhage21.02.01.002; 24.07.03.002---
Breast disorder21.05.04.004---
Malnutrition14.03.02.004---
Invasive breast carcinoma16.10.01.005; 21.05.01.013---
The 1th Page    1    Total 1 Pages